Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 187
Selected: 0
NCT IDTitle
NCT02568449Nintedanib in Treating Patients With Malignant Pleural Mesothelioma That Is Recurrent
NCT02521090EGFRBi-Armed Autologous T Cells in Treating Patients With Recurrent or Refractory Glioblastoma
NCT00972023DHEA in Treating Women Undergoing Surgery for Stage I, Stage II, or Stage III Breast Cancer
NCT00521261Donor T Cells, Low-Dose Aldesleukin, and Low-Dose GM-CSF After Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
NCT03091257A Study of Dabrafenib and/or Trametinib in Patients With Relapsed and/or Refractory Multiple Myeloma
NCT00268255Gefitinib and Radiation Therapy in Treating Patients With Inoperable Stage I or Stage II Non-Small Cell Lung Cancer
NCT06439914First-in-human Study of Interferon-y PET Imaging to Assess Response to Immunotherapy
NCT00369109Skin Biopsies and DNA Analysis in Patients Receiving Irinotecan or Gemcitabine For Advanced Solid Tumors
NCT03147885Selinexor Plus Combination Chemotherapy in Treating Patients With Advanced B Cell Non-Hodgkin Lymphoma
NCT00002908Bryostatin 1 in Treating Patients With Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
NCT00438204Pemetrexed Disodium, Gemcitabine, and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
NCT00984919Biomarker 11-dh-TXB2 in Blood and Urine Samples From Patients With Prostate Cancer and Healthy Volunteers
NCT00217581Bevacizumab, Oxaliplatin, and Docetaxel in Treating Patients With Locally Advanced Unresectable or Metastatic Stomach or Gastroesophageal Junction Cancer
NCT07042191A Provider Intervention to Reduce Financial Toxicity in Patients With Cancer Through Improved Treatment Cost Discussions
NCT01270880Hsp90 Inhibitor STA-9090 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy
NCT03657511Tobacco Cessation Intervention
NCT01416961Integration of Neutron Therapy in the Treatment Plan for Stage III Non-Small Cell Lung Cancer (NSCLC)
NCT00503841Erlotinib in Treating Women Undergoing Surgery For Stage I, Stage II, or Stage III Breast Cancer
NCT02960594hTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse
NCT00258466Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Prostate Cancer
NCT00068653Gefitinib and Celecoxib in Treating Patients With Refractory Non-Small Cell Lung Cancer
NCT02145078Gene Expression Levels in Predicting Treatment Response in Patients With Stage IV Non-small Cell Lung Cancer
NCT00305747Diindolylmethane in Treating Patients With Nonmetastatic Prostate Cancer That Has Not Responded To Previous Hormone Therapy
NCT00938626Treated T Cells Followed by a Stem Cell Transplant in Treating Patients With Multiple Myeloma
NCT05903092MOnaliZumab in Combination With durvAlumab (MEDI4736) Plus Platinum-based chemotheRapy for First-line Treatment of Extensive Stage Small Cell Lung Cancer
NCT01051570Carboplatin, Everolimus, and Prednisone in Treating Patients With Metastatic Prostate Cancer That Progressed After Docetaxel
NCT07227831A Ph II Study of the TheraBionic P1 Device in Subjects With Hormone Positive Breast Cancer
NCT02472275PLX3397, Radiation Therapy, and Antihormone Therapy in Treating Patients With Intermediate- or High-Risk Prostate Cancer
NCT00002907Bryostatin 1 in Treating Patients With Relapsed Multiple Myeloma
NCT06537687Relational Agents in Cervical Cancer Education (RACE)
NCT00559897Zoledronic Acid and Positron Emission Tomography in Treating Patients With Advanced Non-Small Cell Lung Cancer
NCT06501040Increasing Knowledge and Interest in Cancer Clinical Trials
NCT05028374COVID-19 VAX Booster Dosing in Patients With Hematologic Malignancies
NCT04037462Induction of Sensecence Using Dexamethasone to Re-sensitize NSCLC to Anti-PD1 Therapy
NCT00002547Chemotherapy and Bone Marrow Transplantation in Treating Patients Acute Myeloid With Leukemia or Myelodysplastic Syndrome
NCT00872677Weight Loss Counseling for African American Women Who Are Breast Cancer Survivors
NCT00005027Rebeccamycin Analog in Treating Patients With Advanced Kidney Cancer
NCT03252600Lenalidomide, Dexamethasone, and Elotuzumab With or Without Cyclophosphamide in Treating Patients With Relapsed Primary Amyloidosis
NCT00459121Vandetanib, Carboplatin, and Paclitaxel in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Can Be Removed by Surgery
NCT02620865BATS With in Combination With Low Dose IL-1 and GM-CSF for Advanced Pancreatic Cancer
NCT00030407Celecoxib and Docetaxel in Treating Patients With Non-Small Cell Lung Cancer
NCT00003936Bryostatin 1 in Treating Patients With Recurrent or Refractory Hodgkin's Disease
NCT02269267The Life After Stopping Tyrosine Kinase Inhibitors Study (The LAST Study)
NCT03328091Genetic Counseling Processes and Outcomes Among Males With Prostate Cancer (ProGen)
NCT02470559Activated T-cell Therapy, Low-Dose Aldesleukin, and Sargramostim in Treating Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer That is Stage III-IV, Refractory, or Recurrent
NCT00914147Lung Function Testing in Patients With Locally Advanced or Metastatic Solid Tumors
NCT00514215Cryotherapy and GM-CSF in Treating Patients With Lung Metastases or Primary Lung Cancer
NCT07130903Amplitude-Modulated Radiofrequency Electromagnetic Fields (AM RF EMF) in Combination With Fruquintinib in Refractory Metastatic Colorectal Cancer
NCT00906503Fludeoxyglucose F 18-PET/CT Scans in Patients Receiving Ultra Short-Term Dexamethasone For Lung Nodules
NCT07222306Cannabis, Neuroinflammation, and Suicidal Ideation: A Supplemental Brain Imaging Study